Baidu
map

心血管

订阅

MedSci主页 / 所有栏目 / 心血管

急性心肌梗死早期优化再灌注治疗

2015-11-02 傅向华 李伟河北医科大学第二医院 医学论坛网

急性心肌梗死再灌注治疗
关注

STEMI%E6%97%A9%E6%9C%9F%E4%BC%98%E5%8C%96%E5%86%8D%E7%81%8C%E6%B3%A8%E6%B2%BB%E7%96%97%20%5B%E5%8F%AA%E8%AF%BB%5D(1).swf" />

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=151911, encodeId=30ed15191181, content=谢谢，学习有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Oct 29 11:49:04 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489071, encodeId=075f14890e17b, content=<a href='/topic/show?id=7b2130649c9' target=_blank style='color:#2F92EE;'>#再灌注治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30649, encryptionId=7b2130649c9, topicName=再灌注治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33a8492666, createdName=xjy05, createdTime=Tue Nov 03 23:57:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42235, encodeId=83a242235d5, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 13:15:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42190, encodeId=5a5c4219047, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:28:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42188, encodeId=b39142188fb, content=学习啦！, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42189, encodeId=42da42189ac, content=早期开通挽救濒死心机, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2016-10-29 flysky120

    谢谢，学习有帮助

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=151911, encodeId=30ed15191181, content=谢谢，学习有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Oct 29 11:49:04 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489071, encodeId=075f14890e17b, content=<a href='/topic/show?id=7b2130649c9' target=_blank style='color:#2F92EE;'>#再灌注治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30649, encryptionId=7b2130649c9, topicName=再灌注治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33a8492666, createdName=xjy05, createdTime=Tue Nov 03 23:57:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42235, encodeId=83a242235d5, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 13:15:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42190, encodeId=5a5c4219047, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:28:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42188, encodeId=b39142188fb, content=学习啦！, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42189, encodeId=42da42189ac, content=早期开通挽救濒死心机, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-03 xjy05

    #再灌注治疗#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=151911, encodeId=30ed15191181, content=谢谢，学习有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Oct 29 11:49:04 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489071, encodeId=075f14890e17b, content=<a href='/topic/show?id=7b2130649c9' target=_blank style='color:#2F92EE;'>#再灌注治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30649, encryptionId=7b2130649c9, topicName=再灌注治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33a8492666, createdName=xjy05, createdTime=Tue Nov 03 23:57:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42235, encodeId=83a242235d5, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 13:15:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42190, encodeId=5a5c4219047, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:28:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42188, encodeId=b39142188fb, content=学习啦！, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42189, encodeId=42da42189ac, content=早期开通挽救濒死心机, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 玥月

    收藏

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=151911, encodeId=30ed15191181, content=谢谢，学习有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Oct 29 11:49:04 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489071, encodeId=075f14890e17b, content=<a href='/topic/show?id=7b2130649c9' target=_blank style='color:#2F92EE;'>#再灌注治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30649, encryptionId=7b2130649c9, topicName=再灌注治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33a8492666, createdName=xjy05, createdTime=Tue Nov 03 23:57:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42235, encodeId=83a242235d5, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 13:15:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42190, encodeId=5a5c4219047, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:28:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42188, encodeId=b39142188fb, content=学习啦！, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42189, encodeId=42da42189ac, content=早期开通挽救濒死心机, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    收藏

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=151911, encodeId=30ed15191181, content=谢谢，学习有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Oct 29 11:49:04 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489071, encodeId=075f14890e17b, content=<a href='/topic/show?id=7b2130649c9' target=_blank style='color:#2F92EE;'>#再灌注治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30649, encryptionId=7b2130649c9, topicName=再灌注治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33a8492666, createdName=xjy05, createdTime=Tue Nov 03 23:57:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42235, encodeId=83a242235d5, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 13:15:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42190, encodeId=5a5c4219047, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:28:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42188, encodeId=b39142188fb, content=学习啦！, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42189, encodeId=42da42189ac, content=早期开通挽救濒死心机, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    学习啦！

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=151911, encodeId=30ed15191181, content=谢谢，学习有帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Sat Oct 29 11:49:04 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489071, encodeId=075f14890e17b, content=<a href='/topic/show?id=7b2130649c9' target=_blank style='color:#2F92EE;'>#再灌注治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30649, encryptionId=7b2130649c9, topicName=再灌注治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e33a8492666, createdName=xjy05, createdTime=Tue Nov 03 23:57:00 CST 2015, time=2015-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42235, encodeId=83a242235d5, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151019/IMG5624E2925EB643108.jpg, createdBy=ddfd1657548, createdName=玥月, createdTime=Mon Nov 02 13:15:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42190, encodeId=5a5c4219047, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:28:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42188, encodeId=b39142188fb, content=学习啦！, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42189, encodeId=42da42189ac, content=早期开通挽救濒死心机, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 12:27:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    早期开通挽救濒死心机

    0

相关资讯

JAMA：急性心肌梗死后低射血分数患者的植入式心脏除颤器的使用

背景：植入型心律转复除颤器（ICD）不推荐在心肌梗死（MI）后40天内使用；因此，ICD可能不会在MI后护理过程中被考虑。    意义：为了检测ICD植入率和在老年心肌梗死患者死亡率和低射血分数（EF）的相关性。    方法：该回顾性观察研究包括MI后有35％或更低的EF的医疗保险受益人，他们在2007年和2010年间美国441家医院进行

JAMA Intern Med：主动脉内球囊反搏不能改善急性心肌梗死患者的死亡率

主动脉内球囊反搏（IABP）被广泛应用于治疗具有心源性休克的急性心肌梗死的干预中。之前强烈建议的指导方针，最近已经发生了实质性的变化。该研究的目的是评估IABP对于急性心肌梗死患者的疗效。该荟萃分析的数据来自于2014年12月的PubMed，EMBASE和Cochrane图书馆，以及所选文章的参考文献。搜索关键词是“心肌梗死”（ “myocardial infarction” 

JACC：急性心肌梗死后β受体阻滞剂的剂量对生存率的影响

急性心肌梗死（MI）后的β受体阻滞剂治疗可提高生存率。在临床实践中使用β受体阻滞剂的剂量往往比那些在随机试验确定其使用效果的剂量大大降低。该研究评估了急性心肌梗死后β受体阻滞剂的剂量与生存的关系，假设到了高剂量的β受体阻滞剂治疗将提高生存率。一个多中心注册登记了连续7057例急性心肌梗死患者。研究人员将出院后β受体阻滞剂剂量索引到在随机临床试验中使用的目标的β受体阻滞剂剂量，分组为>0％至1

J Intern Med：怕急性心梗吗？那就每天来一杯！！

随着中秋国庆等节假日接踵而至，喝酒是不可回避的话题，酒桌文化也是深入国民的心。喝酒作为日常生活不可或缺的一项饮食文化，与之相关众所周知的酒精肝、肝癌、精神方面疾病、饮酒后的暴力问题等等，使其成为老鼠过街。不过凡事皆有两面，有好有坏。关于饮酒，研究界还是有引人注目的结果：轻中度的酒精摄入可以减少急性心肌梗死的风险。这个结果让很多人鼓舞雀跃。虽然结果让人叹为观止，不过还是有些许问题不清楚有待解救。

NEJM：急性心肌梗死在PCI前使用环孢素没有得到更好的临床效果

实验和临床证据表明，环孢素可以减轻再灌注损伤以及减少心肌梗死面积。该研究的目的是测试环孢素是否能提高临床疗效，防止不良左室重构。在一项多中心，双盲，随机试验中，研究人员分配970例急性前壁ST段抬高心肌梗死（STEMI）并在症状出现后的12小时内采用经皮冠状动脉介入治疗（PCI）的患者，患者的病变冠状动脉已经完全闭塞，在冠状动脉再通之前接受静脉注射环孢素（静脉内给药的剂量为2.5mg每千克体重），

年轻冠心病：病变支数虽少，但多为急性且在重要部位

近年来冠心病的年轻化趋势明显。阜外心血管病医院杨伟宪等进行的研究发现，年轻人患冠心病时，常表现为急性事件；虽以单支病变为主，但近半数患者累及前降支（图1）。因此，得冠心病的年轻人，死亡风险更高。 图1年轻患者急性冠脉综合征和前降支病变比例 研究者还发现，年轻人发生冠心病，以男性多见，且多伴有超重、吸烟、脂代谢异常等心血管危险因素。另外，反应炎性水平的高敏C反应蛋白水平也较高

Baidu
map
Baidu
map
Baidu
map